Adalimumab 53877-0803
Product NDC
53877-0803- Manufacturer
- Terumo Corporation
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- July 1, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab-Fkjp | 20 mg/.4mL |
Packaging Options(1)
180 SYRINGE in 1 BOX (53877-803-01) / .4 mL in 1 SYRINGE